Atherosclerosis-targeted liposome nanocarrier delivery system and preparation method therefor
US-2024424132-A1 · Dec 26, 2024 · US
US2021137881A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021137881-A1 |
| Application number | US-201816492908-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 9, 2018 |
| Priority date | Mar 10, 2017 |
| Publication date | May 13, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I.
Opening claim text (preview).
1 . A compound of formula I: wherein: A is —C(═O)N(R a1 )—R 1 , —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 , —(C 1 -C 3 )alkyl-O —R 1 , —O—R 1 , —(C 1 -C 3 )alkyl-N(R a1 )—R 1 , or —N(R a1 )—R 1 ; each R 1 is independently a (C 3 -C 7 )carbocyclyl, (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl-, 4-7 membered monocyclic heterocyclyl, or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, wherein each (C 3 -C 7 )carbocyclyl or (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl- is independently substituted with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, and wherein each 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is independently optionally substituted with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, wherein each Z is independently selected from the group consisting of NR b2 R c2 , —NHNH 2 , —C(═NR a2 )(NR b2 R c2 ), —NR a2 C(═NR a2 )(R d2 ), and —NR a2 C(═NR a2 )(NR b2 R c2 ) and wherein each (C 3 -C 7 )carbocyclyl, (C 3 -C 7 )carbocyclyl-(C 1 -C 4 )alkyl-, 4-7 membered monocyclic heterocyclyl, or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, is independently optionally substituted independently with one or more (C 1 -C 4 )alkyl; R 2 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy and (C 1 -C 4 )haloalkoxy; R 3 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 4 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 5 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy; R 6 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy and C 1 -C 4 )haloalkoxy; each R a1 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; each R a2 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; each R b2 and R c2 is independently hydrogen, (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; and R d2 is (C 1 -C 6 )alkyl or (C 3 -C 7 )carbocyclyl; or a salt thereof. 2 . The compound or salt of claim 1 , wherein A is —C(═O)N(R a1 )—R 1 , —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 , —(C 1 -C 3 )alkyl-O —R 1 , or —O—R 1 . 3 . The compound or salt of claim 1 , wherein A is —C(═O)N(R a1 )—R 1 . 4 . The compound or salt of claim 1 , wherein A is —(C 1 -C 3 )alkyl-C(═O)N(R a1 )R 1 . 5 . The compound or salt of any one of claims 1 - 4 , wherein R a1 is hydrogen. 6 . The compound or salt of claim 1 , wherein A is —O—R 1 . 7 . The compound or salt of any one of claims 1 - 6 , wherein R 2 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, or (C 1 -C 4 )haloalkoxy. 8 . The compound or salt of any one of claims 1 - 6 , wherein R 2 is hydrogen. 9 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 10 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is phenyl wherein the phenyl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 11 . The compound or salt of any one of claims 1 - 8 , wherein R 3 is 4-fluorophenyl or 4-trifluoromethyphenyl. 12 . The compound or salt of any one of claims 1 - 6 , wherein R 4 is hydrogen, halo, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )haloalkoxy. 13 . The compound or salt of any one of claims 1 - 6 , wherein R 4 is hydrogen. 14 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is aryl or heteroaryl wherein the aryl or heteroaryl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 15 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is phenyl wherein the phenyl is optionally substituted with one or more groups independently selected from halo, —NO 2 , —CN, (C 1 -C 6 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 6 )alkoxy and (C 1 -C 4 )haloalkoxy. 16 . The compound or salt of any one of claims 1 - 13 , wherein R 5 is 4-fluorophenyl or 4-trifluoromethyphenyl. 17 . The compound or salt of any one of claims 1 - 16 , wherein R 6 is hydrogen, halo, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, or (C 1 -C 4 )haloalkoxy. 18 . The compound or salt of any one of claims 1 - 16 , wherein R 6 is hydrogen. 19 . The compound or salt of any one of claims 1 - 6 , wherein the moiety: of the compound of formula I is: 20 . The compound or salt of any one of claims 1 - 17 , wherein R 1 is a 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl-, wherein the 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted independently with one or more groups selected from the group consisting of Z and —(C 1 -C 6 )alkyl substituted with one or more Z, wherein each Z is NR b2 R c2 nd wherein the 4-7 membered monocyclic heterocyclyl or 4-7 membered monocyclic heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted with one or more (C 1 -C 4 )alkyl. 21 . The compound or salt of any one of claims 1 - 17 , wherein R 1 is a 4-7 membered monocyclic N-heterocyclyl or 4-7 membered monocyclic N-heterocyclyl-(C 1 -C 4 )alkyl-, wherein the 4-7 membered monocyclic N-heterocyclyl or 4-7 membered monocyclic N-heterocyclyl-(C 1 -C 4 )alkyl- is optionally substituted independently with one or more groups selected from the group consisting of Z and —(C 1 -C
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Oxygen or sulfur atoms · CPC title
Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose · CPC title
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.